White Borneo Capsules

The White Borneo Capsules from Canopy Kratom exhibit a transparency score of 78.3 out of 100, which corresponds to a grade of C. This score reflects moderate transparency in product quality, with particular strengths and weaknesses across various assessment categories. The Certificate of Analysis (COA) completeness received a score of 74, indicating that while some information is provided, it may lack critical details necessary for comprehensive evaluation. Potency consistency scored 76, suggesting that the product maintains a relatively stable level of active compounds, specifically mitragynine, which averages at 1.35%. However, this concentration is below the market average, raising concerns about the product's overall efficacy. The cost per 100mg of mitragynine is $5.6, significantly higher than the market median of $2.32, indicating that consumers may find this product overpriced relative to its potency. Safety evaluations showed strong performance, with a heavy metal safety score of 82, confirming that all contaminant tests passed. Lab credibility also scored favorably at 80, suggesting that the testing facility is reputable. Despite these positive aspects, the overall value proposition is undermined by the high price and lower-than-average potency. In summary, while Canopy Kratom's White Borneo Capsules are safe and tested by a credible lab, their potency and pricing may not meet the expectations of discerning consumers. It is recommended that potential buyers consider alternative products that offer better value and potency for their investment.